- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 79 publications
- Percutaneous Coronary Intervention , 47 publications
- Purinergic P2Y Receptor Antagonists , 41 publications
- Clopidogrel , 35 publications
Research activity
Active clinical trials
My publications
Filter publications
128 publications
2017
In Vitro Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor-Mediated Signaling in Ticagrelor-Treated Patients.
JACC. Cardiovascular interventions
PubMed • Publisher's site2017
Oral trans-mucosal administration of ticagrelor: is this really the future?
Thrombosis and haemostasis
PubMed • Publisher's site2017
Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
Journal of the American College of Cardiology
PubMed • Publisher's site2017
Switching from ticagrelor to clopidogrel: New answers and further questions.
Thrombosis and haemostasis
PubMed • Publisher's site2017
Switching P2Y12 Receptor Inhibiting Therapies.
Interventional cardiology clinics
PubMed • Publisher's site